PRN: Global Paediatric Vaccine Market to Grow at a CAGR of 15.6% by 2023: Driven by Increasing Government Focus on Immunization Programs

28/lug/2017 16:00:18 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Paediatric Vaccine Market to Grow at a CAGR of 15.6% by 2023: Driven by Increasing Government Focus on Immunization Programs


DUBLIN, July 28, 2017 /PRNewswire/ --

The "Global Paediatric Vaccine Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering.

Research and Markets Logo

Pediatric vaccines are given to a children in its age from 0 - 18 years of age. Congenital Zika is one of the latest pediatric vaccine which found relation in davsstating defects in infants and Zika virus. This leads to contribute in the growth of the pediatric vaccine market with a CAGR of approx 15.65% during forecast period 2016-2023.

The global pediatric vaccine market is driven by increasing government focus on immunization programs, increase in the number of disease among children such as TB, Hepatitis etc. and government funding for the vaccine development. High growth of healthcare sector globally and increase in the expenditure in health industry are the opportunity for the players involved in the pediatricpaedaitic vaccine market to grow.

However, huge capital investment and stringent government regulation for the development of new vaccines and standrads to be followed by governmnrt regarding pediatric vaccine is hampering the demand of the pediatric vaccine market. The major challenge faced by pediatric vaccine market are vaccine cost and inadequate access to vaccine.

Geographically the pediatric vaccine market is bifurcated into North America, Europe, Asia Pacific and RoW. North America gained highest revenue share and is dominating region in pediatric vaccine market. Introduction of new vaccines for all type of diseases and rise in the frequency of occurrence of infectious diseases such as diphtheria, tuberculosis, hepatitis, and pneumococcal disease is aiding the growth of pediatric vaccine market in North America. Moreover, Asia Pacific is the fastest growing region in global pediatric vaccine market due to high annual birth rate which increase the pediatric population in Asian countries such as India, China etc.

Companies Mentioned

  • Pfizer, Inc. (U.S.)
  • Glaxosmithkline, Plc. (U.K.)
  • Merck & Co., Inc. (U.S.)
  • Sanofi Pasteur (France)
  • Emergent Biosolutions, Inc. (U.S.)
  • Johnson & Johnson (India)
  • Medimmune, Llc (U.S.)
  • Astellas Pharma Inc. (Japan)
  • Serum Institute of India (India)
  • Zydua Cadila (India)
  • Emergent Biosolutions Inc. (U.S.)
  • Mitsubishi Tanabe Pharma. (Japan)
  • Takeda Pharmaceutical (Japan)
  • Sinovac Biotech (China)
  • Panacea Biotec(India)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl